Immunic Inc. (IMUX) Misses Q2 EPS by 1c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Pfizer reafffirms 2026 guidance after CFO transition announcement
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy